Skip to main content

Advanced Accelerator Applications USA, Inc.

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20201
20221
20231
20241
Download CSV

FDA Recall Ongoing Historical recordClass II

Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications, 57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61

by Advanced Accelerator Applications USA, Inc.

Reason
CGMP deviations
Published
October 9, 2024
Distribution
FL, MA, NJ, NY, PA, and VA

View recall →

FDA Recall Terminated Historical recordClass III

PLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 vipivotide tetraxetan injection, 9.2 mL Single-dose vial, Manufacturer: Advanced Accelerator Appllications USA, Inc., 57 E. Willow Street NJ 07041, Milburn, USA, NDC 69488-010-61

by Advanced Accelerator Applications USA, Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date
Published
August 23, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

NETSPOT (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, kit contains Vial 1 (Reaction vial with lyophilized powder), 1 Single dose vial, consisting of 40 mcg of dotate, 5 mcg of 1,10-phenanthroline, 6 mcg of Gentisic acid, 20 mg of D-Mannitol, and Nitrogen; and Vial 2, 1 Single dose vial of reaction buffer, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc., by: Gipharma S.r.l., Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40

by Advanced Accelerator Applications USA, Inc.

Reason
Subpotent Drug: low out-of-specification results for Vial 1 assay obtained during stability studies.
Published
April 13, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.

by Advanced Accelerator Applications USA, Inc.

Reason
Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).
Published
January 29, 2020
Distribution
Nationwide

View recall →

Showing 1–4 of 4 results

This page lists recalls that name Advanced Accelerator Applications USA, Inc. as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.